Humanized, mouse or chimeric anti-cd47 monoclonal antibodies
Humanized, mouse or chimeric anti-CD47 monoclonal antibodies are provided. The antibodies bind to human glycosylated and deglycosylated CD47 with an optimized Koff value, they disrupt the human CD47-SIRPα interaction, and find use in various therapeutic, preventive or diagnostic methods. The inventi...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
30.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!